Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea.
Servicio de Alergología, Hospital Rey Juan Carlos, Móstoles, Madrid; Spanish Network on Mastocytosis, Toledo, Spain. Electronic address: ricardo.moreno@hospitalreyjuancarlos.es.
Ricardo
R
Moreno-Borque
Spanish Network on Mastocytosis, Toledo, Spain; Instituto de Estudios de Mastocitosis de Castilla-La Mancha, Hospital Virgen del Valle, Toledo, Spain.
Almudena
A
Matito
Spanish Network on Mastocytosis, Toledo, Spain; Instituto de Estudios de Mastocitosis de Castilla-La Mancha, Hospital Virgen del Valle, Toledo, Spain.
Ivan
I
Álvarez-Twose
Spanish Network on Mastocytosis, Toledo, Spain; Instituto de Estudios de Mastocitosis de Castilla-La Mancha, Hospital Virgen del Valle, Toledo, Spain.
Jose Mario
JM
Morgado
Spanish Network on Mastocytosis, Toledo, Spain; Instituto de Estudios de Mastocitosis de Castilla-La Mancha, Hospital Virgen del Valle, Toledo, Spain.
Laura
L
Sánchez-Muñoz
Spanish Network on Mastocytosis, Toledo, Spain; Servicio General de Citometría, Centro de Investigación del Cáncer/IBMCC (USAL/CSIC) and Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
Alberto
A
Orfao
Spanish Network on Mastocytosis, Toledo, Spain; Servicio General de Citometría, Centro de Investigación del Cáncer/IBMCC (USAL/CSIC) and Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
Luis
L
Escribano
D000068579:Celecoxib / Q000627:therapeutic use*; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D003967:Diarrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D034721:Mastocytosis, Systemic / Q000188:drug therapy*; D008875:Middle Aged
D052246:Cyclooxygenase 2 Inhibitors; D000068579:Celecoxib